Mawer Investment Management Ltd. increased its stake in shares of Danaher Co. (NYSE:DHR) by 1.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 196,844 shares of the conglomerate’s stock after acquiring an additional 2,854 shares during the quarter. Mawer Investment Management Ltd.’s holdings in Danaher were worth $43,727,000 at the end of the most recent quarter.
Other large investors also recently made changes to their positions in the company. Dorsey Wright & Associates raised its stake in Danaher by 7.3% during the 4th quarter. Dorsey Wright & Associates now owns 20,314 shares of the conglomerate’s stock worth $4,513,000 after acquiring an additional 1,382 shares in the last quarter. Financial Consulate Inc. increased its stake in Danaher by 10.4% in the fourth quarter. Financial Consulate Inc. now owns 3,101 shares of the conglomerate’s stock valued at $689,000 after purchasing an additional 291 shares during the period. Dudley & Shanley Inc. increased its stake in Danaher by 29.6% in the fourth quarter. Dudley & Shanley Inc. now owns 82,830 shares of the conglomerate’s stock valued at $18,400,000 after purchasing an additional 18,930 shares during the period. Epiq Partners LLC increased its stake in Danaher by 8.9% in the fourth quarter. Epiq Partners LLC now owns 14,934 shares of the conglomerate’s stock valued at $3,317,000 after purchasing an additional 1,220 shares during the period. Finally, Nisa Investment Advisors LLC increased its stake in Danaher by 37.9% in the fourth quarter. Nisa Investment Advisors LLC now owns 335,894 shares of the conglomerate’s stock valued at $74,615,000 after purchasing an additional 92,380 shares during the period. Hedge funds and other institutional investors own 78.00% of the company’s stock.
DHR stock traded up $0.28 during trading on Tuesday, reaching $225.78. 54,910 shares of the company were exchanged, compared to its average volume of 2,625,056. The company has a market cap of $160.39 billion, a P/E ratio of 45.65, a PEG ratio of 1.92 and a beta of 0.72. Danaher Co. has a 52-week low of $119.60 and a 52-week high of $248.86. The stock’s 50 day moving average price is $237.66 and its 200 day moving average price is $223.22. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.68 and a current ratio of 2.08.
The firm also recently announced a quarterly dividend, which was paid on Friday, January 29th. Shareholders of record on Monday, December 28th were given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date was Thursday, December 24th. Danaher’s payout ratio is currently 16.29%.
A number of research analysts have commented on DHR shares. Needham & Company LLC lifted their price objective on shares of Danaher from $209.00 to $272.00 in a research note on Tuesday, October 27th. Credit Suisse Group lifted their price objective on shares of Danaher from $260.00 to $264.00 and gave the company an “outperform” rating in a research note on Thursday, January 14th. The Goldman Sachs Group initiated coverage on shares of Danaher in a report on Wednesday, December 2nd. They issued a “buy” rating and a $250.00 target price on the stock. Royal Bank of Canada downgraded shares of Danaher from an “outperform” rating to a “sector perform” rating and lowered their target price for the company from $273.00 to $234.00 in a report on Wednesday, November 25th. Finally, KeyCorp initiated coverage on shares of Danaher in a report on Monday, November 9th. They issued an “overweight” rating and a $280.00 target price on the stock. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Danaher presently has an average rating of “Buy” and a consensus target price of $233.00.
In other Danaher news, SVP Angela S. Lalor sold 6,437 shares of Danaher stock in a transaction dated Friday, February 12th. The shares were sold at an average price of $244.70, for a total transaction of $1,575,133.90. Following the completion of the transaction, the senior vice president now owns 25,148 shares in the company, valued at $6,153,715.60. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 11.70% of the company’s stock.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: Special Dividends
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.